Table 2.
Adjusted odds ratios for effects of primary care clinic, primary care physician, and patient factors on guideline concordant pharmacotherapy at 52-weeks
| Level of analysis | Variable | Effect estimate (aOR) | 95% CI | p value |
|---|---|---|---|---|
| Primary Care Clinic (PCC) | Proportion of participants at PCCs with colocated RHE or END | 1.113 | 0.784-1.580 | 0.535 |
| Median proportion of osteoporosis patients at PCCs | 1.010 | 0.605-1.685 | 0.968 | |
| Median proportion of osteopenia patients at PCCs | 0.797 | 0.486-1.309 | 0.355 | |
| Primary Care Physician (PCP) | Median proportion of osteoporosis patients on panel | 0.903 | 0.593-1.374 | 0.633 |
| Median proportion of osteopenia patients on panel | 1.306 | 0.858-1.989 | 0.213 | |
| Age | 0.999 | 0.838-1.192 | 0.994 | |
| Years at KPGA | 0.899 | 0.726-1.114 | 0.331 | |
| Female | 0.758 | 0.549-1.046 | 0.091 | |
| Patient | Intervention vs usual care | 0.963 | 0.761-1.218 | 0.750 |
| PCP ordered the DXA | 1.022 | 0.773-1.351 | 0.880 | |
| Intraclass correlation coefficient | PCCs | 0.004 | -- | -- |
| PCPs | 0.011 | -- | -- |
Bold indicates significance at p ≤ 0.05. Patient covariates are included in the model specification but not displayed (available on request).
aOR = adjusted odds ratio; CI = confidence interval; DXA = dual-energy x-ray absorptiometry; END = endocrinology; KPGA = Kaiser Permanente of Georgia; PCC = primary care clinic; PCP = primary care physician; RHE = rheumatology.